Literature DB >> 20161688

Towards Antitumor Active trans-Platinum Compounds.

Sheena M Aris1, Nicholas P Farrell.   

Abstract

Substitution of NH(3) by a range of amines in trans-[PtCl(2)(NH(3))(2)] produces compounds with cytotoxicity significantly improved over the parent transplatin and in many cases equivalent to that of cisplatin. This microreview summarizes the chemistry and biology of trans-platinum compounds containing principally planar amines and succinctly reviews the current status of anticancer relevance of the trans-platinum geometry. The nature of bifunctional DNA adducts (intrastrand, interstrand) is remarkably dependent on the nature of the amine. Further, the stability of monofunctional adducts allows for competitive production of DNA-protein crosslinks and overall the results suggest that the trans-platinum chemotype may offer significant potential for design of selective DNA-protein crosslinking agents. A subset of proteins known to bind to DNA modified by trans-platinum is that comprised of zinc fingers - model studies show the potential for formation of heteronuclear thiolate-bridged species as precedent for zinc displacement from the biomolecule.

Entities:  

Year:  2009        PMID: 20161688      PMCID: PMC2821104          DOI: 10.1002/ejic.200801118

Source DB:  PubMed          Journal:  Eur J Inorg Chem        ISSN: 1434-1948            Impact factor:   2.524


  71 in total

1.  Thiolate-bridged heterodinuclear platinum-zinc chelates as models for ternary platinum-DNA-protein complexes and zinc ejection from zinc fingers. Evidence from studies using ESI-mass spectrometry.

Authors:  Qin Liu; Melissa Golden; Marcetta Y Darensbourg; Nicholas Farrell
Journal:  Chem Commun (Camb)       Date:  2005-08-10       Impact factor: 6.222

2.  Chemical versatility of transplatin monofunctional adducts within multiple site-specifically platinated DNA.

Authors:  E Bernal-Méndez; M Boudvillain; F González-Vilchez; M Leng
Journal:  Biochemistry       Date:  1997-06-17       Impact factor: 3.162

3.  In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands.

Authors:  M Coluccia; A Nassi; A Boccarelli; D Giordano; N Cardellicchio; D Locker; M Leng; M Sivo; F P Intini; G Natile
Journal:  J Inorg Biochem       Date:  1999-10       Impact factor: 4.155

4.  Enhancement of aqueous solubility and stability employing a trans acetate axis in trans planar amine platinum compounds while maintaining the biological profile.

Authors:  Erin S F Ma; W Douglas Bates; Armistead Edmunds; Lloyd R Kelland; Tito Fojo; Nicholas Farrell
Journal:  J Med Chem       Date:  2005-09-08       Impact factor: 7.446

5.  Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.

Authors:  U M Ohndorf; M A Rould; Q He; C O Pabo; S J Lippard
Journal:  Nature       Date:  1999-06-17       Impact factor: 49.962

6.  Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents.

Authors:  L S Hollis; W I Sundquist; J N Burstyn; W J Heiger-Bernays; S F Bellon; K J Ahmed; A R Amundsen; E W Stern; S J Lippard
Journal:  Cancer Res       Date:  1991-04-01       Impact factor: 12.701

7.  Identification of non-cross-resistant platinum compounds with novel cytotoxicity profiles using the NCI anticancer drug screen and clustered image map visualizations.

Authors:  Tito Fojo; Nick Farrell; Waldo Ortuzar; Hideyuki Tanimura; John Weinstein; Timothy G Myers
Journal:  Crit Rev Oncol Hematol       Date:  2005-01       Impact factor: 6.312

8.  A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.

Authors:  L R Kelland; C F Barnard; K J Mellish; M Jones; P M Goddard; M Valenti; A Bryant; B A Murrer; K R Harrap
Journal:  Cancer Res       Date:  1994-11-01       Impact factor: 12.701

Review 9.  The resurgence of platinum-based cancer chemotherapy.

Authors:  Lloyd Kelland
Journal:  Nat Rev Cancer       Date:  2007-07-12       Impact factor: 60.716

10.  Conformation, protein recognition and repair of DNA interstrand and intrastrand cross-links of antitumor trans-[PtCl2(NH3)(thiazole)].

Authors:  Victoria Marini; Petros Christofis; Olga Novakova; Jana Kasparkova; Nicholas Farrell; Viktor Brabec
Journal:  Nucleic Acids Res       Date:  2005-10-19       Impact factor: 16.971

View more
  24 in total

Review 1.  Synthetic methods for the preparation of platinum anticancer complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Chem Rev       Date:  2013-11-27       Impact factor: 60.622

2.  Geometry matters: inverse cytotoxic relationship for cis/trans-Ru(ii) polypyridyl complexes from cis/trans-[PtCl2(NH3)2].

Authors:  Erin Wachter; Ana Zamora; David K Heidary; José Ruiz; Edith C Glazer
Journal:  Chem Commun (Camb)       Date:  2016-08-09       Impact factor: 6.222

3.  Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting.

Authors:  Katherine S Lovejoy; Stephen J Lippard
Journal:  Dalton Trans       Date:  2009-10-01       Impact factor: 4.390

4.  Platinum-based drugs and proteins: reactivity and relevance to DNA adduct formation.

Authors:  Odra Pinato; Caterina Musetti; Nicholas P Farrell; Claudia Sissi
Journal:  J Inorg Biochem       Date:  2013-01-23       Impact factor: 4.155

5.  Photocytotoxic trans-diam(m)ine platinum(IV) diazido complexes more potent than their cis isomers.

Authors:  Nicola J Farrer; Julie A Woods; Vivienne P Munk; Fiona S Mackay; Peter J Sadler
Journal:  Chem Res Toxicol       Date:  2010-02-15       Impact factor: 3.739

6.  Luminescent iminophosphorane gold, palladium and platinum complexes as potential anticancer agents.

Authors:  Malgorzata Frik; Josefina Jiménez; Vadim Vasilevski; Monica Carreira; Andreia de Almeida; Elena Gascón; Farrah Benoit; Mercedes Sanaú; Angela Casini; María Contel
Journal:  Inorg Chem Front       Date:  2014-03-07       Impact factor: 6.569

7.  Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes.

Authors:  Matthew D Hall; Katherine A Telma; Ki-Eun Chang; Tobie D Lee; James P Madigan; John R Lloyd; Ian S Goldlust; James D Hoeschele; Michael M Gottesman
Journal:  Cancer Res       Date:  2014-05-08       Impact factor: 12.701

8.  Structural basis for the bypass of the major oxaliplatin-DNA adducts by human DNA polymerase η.

Authors:  Hala Ouzon-Shubeita; Meghan Baker; Myong-Chul Koag; Seongmin Lee
Journal:  Biochem J       Date:  2019-02-28       Impact factor: 3.857

9.  Axial ligand exchange of N-heterocyclic cobalt(III) Schiff base complexes: molecular structure and NMR solution dynamics.

Authors:  Lisa M Manus; Robert J Holbrook; Tulay A Atesin; Marie C Heffern; Allison S Harney; Amanda L Eckermann; Thomas J Meade
Journal:  Inorg Chem       Date:  2013-01-02       Impact factor: 5.165

10.  Rational design of [Co(acacen)L2]+ inhibitors of protein function.

Authors:  Lauren M Matosziuk; Robert J Holbrook; Lisa M Manus; Marie C Heffern; Mark A Ratner; Thomas J Meade
Journal:  Dalton Trans       Date:  2013-01-22       Impact factor: 4.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.